Prothena Corp PLC (PRTA)
25.12
-0.95
(-3.64%)
USD |
NASDAQ |
Mar 18, 16:00
25.12
0.00 (0.00%)
After-Hours: 20:00
Prothena Cash from Investing (TTM): -2.773M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.773M |
September 30, 2023 | -1.412M |
June 30, 2023 | -1.10M |
March 31, 2023 | -0.49M |
December 31, 2022 | -0.464M |
September 30, 2022 | -0.632M |
June 30, 2022 | -0.71M |
March 31, 2022 | -0.549M |
December 31, 2021 | -0.575M |
September 30, 2021 | -0.307M |
June 30, 2021 | -0.176M |
March 31, 2021 | -0.222M |
December 31, 2020 | -0.196M |
September 30, 2020 | -0.251M |
June 30, 2020 | -0.423M |
March 31, 2020 | -0.446M |
December 31, 2019 | -0.547M |
September 30, 2019 | -1.738M |
June 30, 2019 | -1.641M |
March 31, 2019 | -1.671M |
December 31, 2018 | -1.729M |
September 30, 2018 | -0.808M |
June 30, 2018 | -1.194M |
Date | Value |
---|---|
March 31, 2018 | -1.303M |
December 31, 2017 | -3.521M |
September 30, 2017 | -10.29M |
June 30, 2017 | -18.31M |
March 31, 2017 | -18.80M |
December 31, 2016 | -16.64M |
September 30, 2016 | -10.48M |
June 30, 2016 | -2.256M |
March 31, 2016 | -1.592M |
December 31, 2015 | -1.382M |
September 30, 2015 | -0.437M |
June 30, 2015 | -0.214M |
March 31, 2015 | -0.501M |
December 31, 2014 | -0.499M |
September 30, 2014 | -0.456M |
June 30, 2014 | -0.577M |
March 31, 2014 | -0.451M |
December 31, 2013 | -0.535M |
September 30, 2013 | -1.565M |
June 30, 2013 | -1.441M |
March 31, 2013 | -1.274M |
December 31, 2012 | -1.301M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.773M
Minimum
Dec 2023
-0.176M
Maximum
Jun 2021
-0.8162M
Average
-0.548M
Median
Cash from Investing (TTM) Benchmarks
Amarin Corp PLC | -25.52M |
Jazz Pharmaceuticals PLC | -163.06M |
Iterum Therapeutics PLC | 14.19M |
GH Research PLC | -54.10M |
Mural Oncology PLC | -- |